• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by Lazard LTD. Lazard LTD. (Amendment)

    2/14/22 2:34:37 PM ET
    $LAZ
    Investment Managers
    Finance
    Get the next $LAZ alert in real time by email
    SC 13G/A 1 laz13gadec21.txt UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2) Lazard Ltd (Name of Issuer) COMMON STOCK (Title of Class of Securities) G54050102 (CUSIP NUMBER) December 31, 2021 (Date of Event which Requires Filing of Statement) Check the appropriate box to designate the Rule pursuant to which this Schedule is filed: [x] Rule 13d - 1(b) Rule 13d - 1(c) Rule 13d - 1(d) 1. Name of Reporting Person T. ROWE PRICE ASSOCIATES, INC. 52-0556948 2. Check the Appropriate Box if a Member of a Group NOT APPLICABLE 3. SEC Use Only 4. Citizenship or Place of Organization Maryland Number of Shares Beneficially Owned by Each Reporting Person With 5. Sole Voting Power* 1,377,195 6. Shared Voting Power* 0 7. Sole Dispositive Power* 3,378,916 8. Shared Dispositive Power 0 9. Aggregate Amount Beneficially Owned by Each Reporting Person 3,378,916 10. Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares NOT APPLICABLE 11. Percent of Class Represented by Amount in Row 9 2.9% 12. Type of Reporting Person IA *Any shares reported in Items 5 and 6 are also reported in Item 7. Item 1(a) Name of Issuer: Lazard Ltd Item 1(b) Address of Issuer's Principal Executive Offices: CLARENDON HOUSE, 2 CHURCH STREET, HAMILTON, BERMUDA HM II Item 2(a) Name of Person(s) Filing: (1) T. ROWE PRICE ASSOCIATES, INC. ("Price Associates") Item 2(b) Address of Principal Business Office: 100 E. Pratt Street, Baltimore, MD 21202 Item 2(c) Citizenship or Place of Organization: (1) Maryland Item 2(d) Title of Class of Securities: COMMON STOCK Item 2(e) Cusip Number: G54050102 Item 3: The person filing this Schedule 13G is an: X Investment Adviser registered under Section 203 of the Investment Advisers Act of 1940 Item 4: Reference is made to Items 5-11 on the preceding pages of this Schedule 13G. Item 5: Ownership of Five Percent or Less of a Class This statement is being filed to report the fact that, as of the date of this report, the reporting person(s) has (have) ceased to be the beneficial owner of more than five percent of the class of securities. Item 6: Ownership of More than Five Percent on Behalf of Another Person (1) Price Associates does not serve as custodian of the assets of any of its clients; accordingly, in each instance only the client or the client's custodian or trustee bank has the right to receive dividends paid with respect to, and proceeds from the sale of, such securities. The ultimate power to direct the receipt of dividends paid with respect to, and the proceeds from the sale of, such securities, is vested in the individual and institutional clients which Price Associates serves as investment adviser. Any and all discretionary authority which has been delegated to Price Associates may be revoked in whole or in part at any time. Except as may be indicated if this is a joint filing with one of the registered investment companies sponsored by Price Associates which it also serves as investment adviser ("T. Rowe Price Funds"), not more than 5% of the class of such securities is owned by any one client subject to the investment advice of Price Associates. (2) With respect to securities owned by any one of the T. Rowe Price Funds, only the custodian for each of such Funds, has the right to receive dividends paid with respect to, and proceeds from the sale of, such securities. No other person is known to have such right, except that the shareholders of each such Fund participate proportionately in any dividends and distributions so paid. Item 7: Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company. Not Applicable Item 8: Identification and Classification of Members of the Group Not Applicable Item 9: Notice of Dissolution of Group Not Applicable Item 10: Certification By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. T. Rowe Price Associates, Inc. hereby declares and affirms that the filing of Schedule 13G shall not be construed as an admission that Price Associates is the beneficial owner of the securities referred to, which beneficial ownership is expressly denied. Signature. After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. T. ROWE PRICE ASSOCIATES, INC. Date: February 14, 2022 Signature: /s/ David Oestreicher Name & Title: David Oestreicher, Executive Vice President 12/31/2021
    Get the next $LAZ alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $LAZ

    DatePrice TargetRatingAnalyst
    10/3/2025$56.00Market Perform
    BMO Capital Markets
    8/25/2025$65.00Mkt Perform → Outperform
    Keefe Bruyette
    4/7/2025$56.00 → $33.00Equal-Weight → Underweight
    Morgan Stanley
    1/3/2025Outperform → Peer Perform
    Wolfe Research
    12/20/2024$65.00 → $57.00Outperform → Mkt Perform
    Keefe Bruyette
    12/9/2024$60.00 → $63.00Overweight → Equal-Weight
    Morgan Stanley
    9/12/2024$51.00Equal Weight
    Wells Fargo
    1/29/2024$51.00Outperform
    Keefe Bruyette
    More analyst ratings

    $LAZ
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    BMO Capital Markets initiated coverage on Lazard with a new price target

    BMO Capital Markets initiated coverage of Lazard with a rating of Market Perform and set a new price target of $56.00

    10/3/25 8:41:45 AM ET
    $LAZ
    Investment Managers
    Finance

    Lazard upgraded by Keefe Bruyette with a new price target

    Keefe Bruyette upgraded Lazard from Mkt Perform to Outperform and set a new price target of $65.00

    8/25/25 8:08:17 AM ET
    $LAZ
    Investment Managers
    Finance

    Lazard downgraded by Morgan Stanley with a new price target

    Morgan Stanley downgraded Lazard from Equal-Weight to Underweight and set a new price target of $33.00 from $56.00 previously

    4/7/25 7:56:16 AM ET
    $LAZ
    Investment Managers
    Finance

    $LAZ
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Lazard Reports Third Quarter and Nine Month 2025 Results

    Record firmwide adjusted net revenue for the third quarter of $725 million, up 12% year-over-year Record Financial Advisory adjusted net revenue of $1.3 billion for the first nine months of 2025, with 20 Managing Directors hired year-to-date to support long-term growth Record Asset Management inflows for the third quarter and first nine months of the year, with positive net flows of $1.6 billion and total AUM up 17% year-to-date Lazard, Inc. (NYSE:LAZ) today reported net revenue of $748 million and record adjusted net revenue1 of $725 million for the quarter ended September 30, 2025. For the first nine months of 2025, Lazard reported net revenue of $2,192 million and adjusted net

    10/23/25 6:30:00 AM ET
    $LAZ
    Investment Managers
    Finance

    Lazard Global Total Return and Income Fund Declares Monthly Distribution and Issues Estimated Sources of the Distribution Announced in September

    Lazard Global Total Return and Income Fund, Inc. (the "Fund") (NYSE:LGI) is confirming today, pursuant to its Managed Distribution Policy, as previously authorized by its Board of Directors, a monthly distribution of $0.14646 per share on the Fund's outstanding common stock. The distribution is payable on November 24, 2025, to shareholders of record on November 12, 2025. The ex-dividend date is November 12, 2025. The Fund will pay a previously declared distribution today, October 22, 2025. The following table sets forth the estimated amounts of the current distribution and the cumulative distributions paid, including today's distribution, from the following sources: net investment income,

    10/22/25 6:00:00 PM ET
    $LAZ
    $LGI
    Investment Managers
    Finance

    Lazard Declares Quarterly Dividend of $0.50 Per Share

    Lazard, Inc. (NYSE:LAZ) today announced that its Board of Directors has voted to declare a quarterly dividend of $0.50 per share on its outstanding common stock. The dividend is payable on November 14, 2025, to stockholders of record on November 3, 2025. About Lazard Founded in 1848, Lazard is the preeminent financial advisory and asset management firm, with operations in North and South America, Europe, the Middle East, Asia, and Australia. Lazard provides advice on mergers and acquisitions, capital markets and capital solutions, restructuring and liability management, geopolitics, and other strategic matters, as well as asset management and investment solutions to institutions, corpor

    10/22/25 4:15:00 PM ET
    $LAZ
    Investment Managers
    Finance

    $LAZ
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Director Shevelenko Dmitry

    4 - Lazard, Inc. (0001311370) (Issuer)

    9/18/25 4:30:18 PM ET
    $LAZ
    Investment Managers
    Finance

    CEO & Chairman Orszag Peter Richard converted options into 64,949 shares, returned $1,083,171 worth of shares to the company (19,485 units at $55.59) and sold $1,756,573 worth of shares (32,475 units at $54.09), increasing direct ownership by 8% to 183,274 units (SEC Form 4)

    4 - Lazard, Inc. (0001311370) (Issuer)

    9/17/25 8:06:50 PM ET
    $LAZ
    Investment Managers
    Finance

    CEO of Asset Management Russo Evan L gifted 15,000 shares and sold $4,240,260 worth of shares (75,000 units at $56.54), decreasing direct ownership by 28% to 227,915 units (SEC Form 4)

    4 - Lazard, Inc. (0001311370) (Issuer)

    9/11/25 7:27:29 PM ET
    $LAZ
    Investment Managers
    Finance

    $LAZ
    SEC Filings

    View All

    Lazard Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - Lazard, Inc. (0001311370) (Filer)

    10/23/25 6:30:24 AM ET
    $LAZ
    Investment Managers
    Finance

    SEC Form 144 filed by Lazard Inc.

    144 - Lazard, Inc. (0001311370) (Subject)

    9/10/25 4:41:06 PM ET
    $LAZ
    Investment Managers
    Finance

    Lazard Inc. filed SEC Form 8-K: Regulation FD Disclosure

    8-K - Lazard, Inc. (0001311370) (Filer)

    9/10/25 8:00:24 AM ET
    $LAZ
    Investment Managers
    Finance

    $LAZ
    Leadership Updates

    Live Leadership Updates

    View All

    Lazard Appoints Edouard Panié as Managing Director and Co-Head of European Financial Sponsors Coverage

    Lazard, Inc. (NYSE:LAZ) today announced the appointment of Edouard Panié as Managing Director and Co-Head of the European Financial Sponsors Coverage. He will report to Klaus H. Hessberger, Global Co-Head and Head of Europe for Lazard's Financial Sponsors Group, to further strengthen the firm's presence and partnerships with financial sponsors across the region. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251019307537/en/Edouard Panié Mr. Panié joins from Goldman Sachs, where he was a Managing Director for nearly two decades, advising on more than 60 landmark M&A, debt, and equity transactions for leading alternative asset ma

    10/20/25 2:00:00 AM ET
    $LAZ
    Investment Managers
    Finance

    Lazard Welcomes Cyrille Cotte as Managing Director and Head of Insurance for European Financial Institutions

    Lazard, Inc. (NYSE:LAZ) today announced the appointment of Cyrille Cotte as Managing Director and Head of Insurance for its European Financial Institutions Group (FIG), based in London and working across Europe with regional Co-Heads of Financial Services Coverage Nick Millar and Corso Bavagnoli. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250930678445/en/Cyrille Cotte Cyrille joins Lazard from Evercore, where he was a Partner and Senior Managing Director in the European Financial Institutions Group. Over his career, he has focused on advising a broad range of insurers and other financial services firms on mergers, acquisitio

    10/1/25 2:00:00 AM ET
    $LAZ
    Investment Managers
    Finance

    Lazard Hires Geoffrey Porges to Healthcare Advisory Group

    Lazard announced today that Dr. Geoffrey Porges has joined the firm as Managing Director in the Healthcare Advisory Group, advising on transactions across diversified biopharmaceuticals. "We are thrilled to welcome Geoffrey to Lazard," said David Gluckman, Vice Chairman of Investment Banking and Global Head of Healthcare. "His deep understanding of the biopharmaceutical industry's strategic and financial landscape, coupled with his ability to help companies translate scientific innovation into actionable business strategies, will empower our clients to strengthen their competitive positions, capitalize on growth opportunities, and build resilient companies in a challenging geopolitical an

    9/18/25 7:00:00 AM ET
    $LAZ
    Investment Managers
    Finance

    $LAZ
    Financials

    Live finance-specific insights

    View All

    Lazard Reports Third Quarter and Nine Month 2025 Results

    Record firmwide adjusted net revenue for the third quarter of $725 million, up 12% year-over-year Record Financial Advisory adjusted net revenue of $1.3 billion for the first nine months of 2025, with 20 Managing Directors hired year-to-date to support long-term growth Record Asset Management inflows for the third quarter and first nine months of the year, with positive net flows of $1.6 billion and total AUM up 17% year-to-date Lazard, Inc. (NYSE:LAZ) today reported net revenue of $748 million and record adjusted net revenue1 of $725 million for the quarter ended September 30, 2025. For the first nine months of 2025, Lazard reported net revenue of $2,192 million and adjusted net

    10/23/25 6:30:00 AM ET
    $LAZ
    Investment Managers
    Finance

    Lazard Global Total Return and Income Fund Declares Monthly Distribution and Issues Estimated Sources of the Distribution Announced in September

    Lazard Global Total Return and Income Fund, Inc. (the "Fund") (NYSE:LGI) is confirming today, pursuant to its Managed Distribution Policy, as previously authorized by its Board of Directors, a monthly distribution of $0.14646 per share on the Fund's outstanding common stock. The distribution is payable on November 24, 2025, to shareholders of record on November 12, 2025. The ex-dividend date is November 12, 2025. The Fund will pay a previously declared distribution today, October 22, 2025. The following table sets forth the estimated amounts of the current distribution and the cumulative distributions paid, including today's distribution, from the following sources: net investment income,

    10/22/25 6:00:00 PM ET
    $LAZ
    $LGI
    Investment Managers
    Finance

    Lazard Declares Quarterly Dividend of $0.50 Per Share

    Lazard, Inc. (NYSE:LAZ) today announced that its Board of Directors has voted to declare a quarterly dividend of $0.50 per share on its outstanding common stock. The dividend is payable on November 14, 2025, to stockholders of record on November 3, 2025. About Lazard Founded in 1848, Lazard is the preeminent financial advisory and asset management firm, with operations in North and South America, Europe, the Middle East, Asia, and Australia. Lazard provides advice on mergers and acquisitions, capital markets and capital solutions, restructuring and liability management, geopolitics, and other strategic matters, as well as asset management and investment solutions to institutions, corpor

    10/22/25 4:15:00 PM ET
    $LAZ
    Investment Managers
    Finance

    $LAZ
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Lazard Inc.

    SC 13G - Lazard, Inc. (0001311370) (Subject)

    11/8/24 2:17:07 PM ET
    $LAZ
    Investment Managers
    Finance

    SEC Form SC 13G/A filed by Lazard LTD. Lazard LTD. (Amendment)

    SC 13G/A - Lazard, Inc. (0001311370) (Subject)

    2/14/24 9:41:26 AM ET
    $LAZ
    Investment Managers
    Finance

    SEC Form SC 13G/A filed by Lazard LTD. Lazard LTD. (Amendment)

    SC 13G/A - Lazard, Inc. (0001311370) (Subject)

    2/9/24 9:16:05 AM ET
    $LAZ
    Investment Managers
    Finance